Biological Drugs Market to Exhibit Significant Incremental Dollar Opportunity During the Forecast Period
Home Business & Finans Biological Drugs Market to Exhibit Significant Incremental Dollar Opportunity During the Forecast Period
According to a new market report published by Persistence Market Research “Global Market Study on Biological Drugs: North America to Witness Highest Growth By 2020”, the global biological drugs market was valued at US$ 161,056.5 Mn in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach US$ 287,139.7 Mn by 2020.
Biological drugs are typically derived from living cells and are used in the prevention and treatment of various diseases such as cancer, blood disorders, auto-immune diseases, and other medical disorders. Biological drugs have more complex structures compared to that of conventional drugs.
Globally, the biological drugs market is witnessing significant growth due to the increasing prevalence of chronic diseases and growing geriatric population. In addition, health and awareness initiatives by various government associations are also supporting the growth of the biological drugs market. However, high costs of biological drugs and patent expiry of blockbuster drugs impede the growth of the biological drugs market. Moreover, risks of adverse effects associated with biologic injectable drugs also inhibit the growth of the market.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/2883
The global biological drugs market is anticipated to grow from an estimated US$ 161,056.5 Mn in 2014 to US$ 287,139.7 Mn by 2020 at a CAGR 10.1% during the forecast period.
North America dominates the global biological drugs market. This is due to increasing use of biological drugs in the treatment of diseases such as cancer, diabetes, and other chronic diseases in the region. In addition, several clinics in the region are focusing on biological drugs for the treatment of various diseases.
The biological drugs market in Europe is growing due to increasing aging population in the region. For instance, according to a UN report, elderly people accounted for 23.2% of the total population in Germany in 2000, and the number is expected to reach 33.2% by 2025. Aging can lead to certain disorders such as age-related macular degeneration and glaucoma, which require effective biological drugs for their treatment.
Low manufacturing costs in Asia are attracting biopharmaceutical companies to invest in the region, supporting the growth of the biological drugs market. Moreover, governments of some Asian countries are also supporting the growth of the biological drugs market by providing funds to life sciences research institutes and biotech companies for the construction of R&D and manufacturing facilities.
Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/2883
Novartis AG, Pfizer Inc., GlaxoSmithKline plc., and Merck & Co., Inc. are some of the leading players in the global biological drugs market. Other major players in the market include Abbott Laboratories, Baxter International Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Biogen Idec, and Amgen Inc.
The global biological drugs market is segmented as follows:
By therapeutic protein,Enbrel,Lantus,Neulasta,Avonex,NovoLog,Rebif,Humalog,Aranesp,Epogen,Levemir,Victoza,Betaseron,Neupogen,Eylea,By monoclonal antibody (mAb),Humira,Remicade,Rituxan,Avastin,Herceptin,Lucentis,By vaccine,Prenvar 13,Gardasil,Fluzone,Varivax,Cervarix,By geography,North America,Europe,Asia,Rest of the World (RoW)
Previous PostManufacturers of E Clinical Solution Market to Benefit from Lucrative Growth Opportunities on Account of Increasing Adoption Next PostDemand for Treatment Syndromes Dementia Movement Disorders Market Driven by Shifting Consumer Perceptions and Growing Awareness